Google
DXR — DAXOR CORPORATION (Healthcare >> Medical Instruments & Supplies)
DXR FAQ
What is DXR's P/E ratio?
DAXOR CORPORATION (DXR) currently trades at a P/E ratio of 4.48.
What is DXR's ROE?
DAXOR CORPORATION reports a Return on Equity (ROE) of 19.98%.
What is DXR's dividend yield?
DAXOR CORPORATION offers a dividend yield of 0.00%.
What is DXR's Deepscope Quality Score?
Deepscope rates DXR's overall financial quality at 100 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy DXR?
Deepscope's AI Timing Score for DXR is 0 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does DXR belong to?
DAXOR CORPORATION is classified under the Healthcare >> Medical Instruments & Supplies sector on the NASDAQ exchange.
|
USD 10.36
Price
0.30
(2.93%)
Day Change
|
|
|---|
DXR, ファンダメンタルスコアはexcellent ( ファンダメンタル = 100) but テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- OUTPERFORM
- Signal Description
- Company financial health is Excellent
- Reason
-
Company financial health is Excellent from almost all quality indicators
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not quite good , financial health is not good , and ability to make profit is good , ...
| Deepscope 分析 |
|
58% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
1230
|
| Magic Formula Rank by ROE |
1230
|
| Magic Formula Rank by ROIC |
1524
|
| Price | 10.36 |
| PBV / Sector |
1.14 / 4.45
GREAT
|
| Earning Per Share | 1.84 |
| PE / Sector |
4.48 / 35.84
GREAT
|
| PEG or PE/Growth / Sector |
-1.25 / -1.20
|
| Average 1M Daily Value |
0.08 M
GREAT
|
| Average 1W Daily Value |
0.02 M
GREAT
|
| Timing Factors |
|
14% |
| Financial Health |
|
41% |
| ポイントになる統計 |
|
77% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-06-03 09:11:05 |
| Symbol | DXR |
| Name | DAXOR CORPORATION |
| Sector | Healthcare >> Medical Instruments & Supplies |
| Market | NASDAQ |
| Listed Shares | 5.83 M |
| Par Value | N/A |
| Calculated From | YearEnd |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 52.39 / 15,373.89 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 109 Meco Lane, Oak Ridge, TN, United States, 37830
Phone: 865-425-0555
Website: https://www.daxor.com
Description: Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation operates as a subsidiary of Estate Of Joseph Feldschuh.
ME vs SECTOR Healthcare >> Medical Instruments & Supplies
Click a bubble to view stock details · Bubble size represents market capitalization share
